A study found that hospital sink drains harbor dangerous bacteria, including antibiotic-resistant strains. Despite thorough ...

Klebsiella pneumoniae, a dangerous bacterium responsible for pneumonia, has been discovered in Ukraine. Experts are alarmed as the bacterium is drug-resistant, and scientists believe it poses a ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

肺炎克雷伯菌（Klebsiella ...

Overuse of antibiotics is the main cause of the so-called “silent pandemic” of AMR infections, with a type of infection called Klebsiella pneumoniae now becoming a major issue for hospitals ...

Carbapenem-resistant Enterobacterales (CRE), including carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Escherichia coli, pose a major risk to patients and healthcare systems in the ...

A recent study has revealed that a fibre-rich diet may help protect against potentially life-threatening infections caused by harmful bacteria such as Klebsiella pneumoniae and E. coli. By influencing ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...